Study urine tests to help screen for cancer
Part of Cancer clinical trials.
This study looks for a new set of urine “markers” (measurable substances in urine) that may help detect cancer earlier. If you join, they will collect your urine and compare results between people with cancer and people without cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be older than 18 years
- If you have cancer, you need a confirmed cancer diagnosis (from tissue testing/biopsy)
- If you are in the control group, your medical record should not show a cancer diagnosis
- You must not have had a urine tract infection in the last 6 weeks
- You must not have had procedures down the urethra (like a catheter or cystoscopy) in the last 6 weeks
- You must be able and willing to give consent to join
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests non-invasive tests (using urine samples and scheduled bladder procedures) to help detect bladder cancer. It may be helpful if you are having bladder evaluation or surgery and your care team wants better ways to detect cancer without invasive testing beyond what you already need.
This study is testing a new blood test to help doctors find cancer earlier. If you are 45 or older and have symptoms that might be cancer, or were recently diagnosed with cancer, you may be able to join.
This study checks whether a lab test using your urine and blood (plasma) can detect signs of cancer early in people who don’t have symptoms. It compares people with newly found cancer to people without cancer to see how accurate the test is.
This study measures “circulating tumor markers,” meaning substances from cancer that can show up in blood, to better understand how cancer is doing after treatment. You may join if you recently received cancer care at a participating center and meet basic study and follow-up requirements.
This trial looks at the microbes in your body (mostly from samples) to find clues—called biomarkers—that may help doctors understand or track cancer. You might be asked to share health information and provide samples before or around the time you start cancer treatment.
This study looks for new urine markers (signals) that could help screen for prostate cancer. If you have a higher PSA blood test and are scheduled for a prostate biopsy, your urine sample may be studied to see if it can improve screening.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.